Read Simon (CIK 1688199) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-19). Recent activity: Buy DNTH (2,778 shares), Sell DNTH (2,778 shares), Buy DNTH (2,777 shares), Sell DNTH (70 shares), Sell DNTH (737 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Buy | 2,778 | $51,004 |
| 2026-08-19 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 2,778 | $326,554 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Buy | 2,777 | $50,986 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 70 | $7,498 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 737 | $79,721 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 831 | $90,537 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 272 | $29,909 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 470 | $52,194 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 397 | $44,373 |
Source: SEC Form 4 filings · as of 2026-08-19